Nabumetone
Product Images NDC 10544-271

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Nabumetone (NDC 10544-271). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 500mg 60ct (10544 003 60 68462 358 05 Rev1)

This is a description of nabumetone tablets, USP used for medicinal purposes. They come in 500mg and 50 or 60 tablet packages. The controlled room temperature required for storage is 20-25°C. The tablets must be kept in a tight, child-resistant container out of the reach of children. The lot and expiration dates are noted. The tablets contain 500mg of nabumetone, USP. Different manufacturers are listed along with the product codes and dosage.*

FDA Label Image

Structural Formula Of Nabumetone (5276f530 14bc 492d 974b 913fd06bf52e 01)

FDA Label Image

6mna (5276f530 14bc 492d 974b 913fd06bf52e 02)

COOH represents carboxylic acid functional group. CH40 may be a typographical error or an incompletely scanned text. 6-methoxy-2-naphthylacetic acid (6MNA) is an organic compound that belongs to the class of naphthalenes. It is a white to yellowish solid and has various applications in the pharmaceutical industry.*

FDA Label Image

Table 1 (5276f530 14bc 492d 974b 913fd06bf52e 03)

FDA Label Image

6mna Plasma Concentrations (5276f530 14bc 492d 974b 913fd06bf52e 04)

This is a graph displaying Nabumetone Active Metabolite (6MNA) plasma concentrations at steady state following once-daily dosing of Nabumetone 1000 mg and 2000 mg. The graph shows the plasma concentration levels of the drug at different time intervals against the dose given. The x-axis represents time in hours, and the y-axis represents the plasma concentration in ng/mL. There are two lines in the graph showing the plasma concentration, one for 1000 mg dose, and the other for 2000 mg. The graph shows that the plasma concentration of the drug increases with increasing dose and reaches steady state levels.*

FDA Label Image

Metabolites (5276f530 14bc 492d 974b 913fd06bf52e 05)

This appears to be a list of different forms and percentages of metabolites of a drug called nabumetone. The drug undergoes various processes such as conjugation and remaining unchanged, leading to different forms such as 6-methoxy-2-naphthylacetic acid (6MNA) and 6-hydroxy-2-naphthylacetic acid (6HNA). The text also suggests that some minor metabolites were observed, and the percentage of different forms of metabolites in total dose ranges from not detectable to 73%.*

FDA Label Image

Table 2 (5276f530 14bc 492d 974b 913fd06bf52e 06)

This appears to be a table showing the mean/mode duration of treatment in years for patients with RA (rheumatoid arthritis) who were given different doses of Nabumetone (a pain reliever). The table also includes the number of patients who received each dose and some additional data.*

FDA Label Image

Side Effects Table (5276f530 14bc 492d 974b 913fd06bf52e 07)

This text is a description of serious and other side effects that can be caused by a medication. It lists several severe health problems such as heart attack, stroke, kidney failure, and liver failure, as well as life-threatening skin and allergic reactions. It also mentions that people with asthma may experience asthma attacks. In addition, the text also lists less severe side effects like stomach pain, constipation, diarrhea, gas, heartburn, nausea, vomiting, and dizziness.*

FDA Label Image

Get Emergency Help If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 08)

This appears to be a list of symptoms that may indicate a medical emergency. The symptoms include shortness of breath or difficulty breathing, slurred speech, chest pain, swelling of the face or throat, and weakness on one side of the body. If someone is experiencing any of these symptoms, they should seek medical attention immediately.*

FDA Label Image

Stop Nsaid If You Experience These Symptoms (5276f530 14bc 492d 974b 913fd06bf52e 09)

This text describes various symptoms and warning signs related to health issues such as nausea, tiredness, itching, stomach pain, flu-like symptoms, vomiting blood, unusual weight gain, skin rash, blisters with fever, and swelling of the arms, legs, hands, and feet. It also mentions specific warning signs such as yellowing of the skin or eyes, blood in bowel movements or black, sticky stool. These symptoms may indicate an underlying health condition that requires medical attention.*

FDA Label Image

Nsaid Medications That Need A Prescription (5276f530 14bc 492d 974b 913fd06bf52e 10)

FDA Label Image

Glenmark Logo (5276f530 14bc 492d 974b 913fd06bf52e 11)

FDA Label Image

Label 750mg 60ct (Label Nabumetone Tabs 750mg Bpi(10544 271 60) Glenmark(68462 359 05) Rev3)

This text is describing a medication called Nabumetone, which is a tablet. Each tablet has a strength of 750mg, and a package contains 60 tablets. The medication is only available with a prescription and the recommended dosage is described in the package insert. It should be stored at a controlled room temperature and kept out of the reach of children. The text also provides information about the manufacturer of the medication, MFG number, lot number, expiration date, and store location.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.